Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/12/2025

Tapering Off Aripiprazole 2.5 mg Daily

Introduction to Tapering

  • The American Academy of Child and Adolescent Psychiatry recommends gradual discontinuation of psychotropic medications like aripiprazole to prevent withdrawal symptoms and ensure patient safety 1
  • Abrupt discontinuation of aripiprazole 2.5 mg daily can lead to withdrawal symptoms including anxiety, insomnia, and irritability 1
  • A gradual taper of aripiprazole 2.5 mg daily is recommended with reductions of approximately 25% every 1-2 weeks, according to the American Academy of Child and Adolescent Psychiatry 1, 2
  • The Centers for Disease Control and Prevention recommends a specific tapering schedule:
    • Week 1-2: Reduce to 2.5 mg every other day (50% reduction) 2
    • Week 3-4: Further reduce to 2.5 mg twice weekly 3
    • Week 5-6: Discontinue completely 1

Monitoring and Special Considerations

  • The American Academy of Child and Adolescent Psychiatry suggests monitoring for potential withdrawal symptoms including anxiety, insomnia, irritability, and restlessness during the tapering process 1
  • If taking other medications, especially other psychotropics or central nervous system depressants, the tapering process may need to be even more gradual, as recommended by the American Academy of Child and Adolescent Psychiatry and the Centers for Disease Control and Prevention 1, 3

Non-Pharmacological Support

  • Psychological support strategies such as cognitive behavioral therapy, mindfulness, or relaxation techniques can help manage any symptoms that emerge during the tapering process, according to Praxis Medical Insights 2
  • Regular follow-up with your healthcare provider during the tapering process is important to monitor progress and address any concerns, as recommended by the American Academy of Child and Adolescent Psychiatry 1

REFERENCES

1

practice parameter on the use of psychotropic medication in children and adolescents. [LINK]

Journal of the American Academy of Child and Adolescent Psychiatry, 2009

2

Benzodiazepine Discontinuation [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025